0
0
0
0
1
2
3
$0
Is AbbVie solid or fragile? The Finex Financial Health Scanner reads ABBV's real financial statements and scores its debt, liquidity, margins, cash flow and growth, with the Altman Z-score, the Piotroski F-score and the red flags explained in plain words.
| Revenue (FY2025) | $61.2B |
|---|---|
| Net income | $4.2B |
| Operating margin | 24.6% |
| Net margin | 6.9% |
| Cash and investments | $5.3B |
| Total debt | $67.5B |
| Free cash flow | $17.7B |
| Revenue growth (1 year) | 8.6% |
Data: Nasdaq and Yahoo Finance. Educational, not financial advice.